Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01404351

Use of the PEAK PlasmaBlade 4.0 in Bilateral Breast Reduction

A Prospective, Randomized, Controlled Superiority Study to Evaluate Use of the PEAK PlasmaBlade® 4.0 in Bilateral Breast Reduction

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Medtronic Surgical Technologies · Industry
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The objective of this clinical study is to evaluate the operative performance of the PEAK PlasmaBlade® 4.0 during bilateral breast reduction; to monitor and record post-operative pain, adverse events and skin scarring following surgery; and to compare these outcomes to the HARMONIC SYNERGY® BLADE.

Conditions

Interventions

TypeNameDescription
DEVICEPEAK PlasmaBlade
PROCEDUREScalpel and Traditional Electrosurgery

Timeline

Start date
2011-05-01
Primary completion
2011-10-01
Completion
2011-11-01
First posted
2011-07-28
Last updated
2013-01-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01404351. Inclusion in this directory is not an endorsement.

Use of the PEAK PlasmaBlade 4.0 in Bilateral Breast Reduction (NCT01404351) · Clinical Trials Directory